LB Pharmaceuticals Stock Price, News & Analysis
LBRX
NASDAQ
Company Description
Welcome to the overview page for LB Pharmaceuticals (LBRX), where you can find comprehensive stock information and company updates.
Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.
Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.
Stock Performance
Latest News
SEC Filings
Financial Highlights
$3,556
Net Income (TTM)
$0.61
$17,105
Operating Cash Flow
47.60
—
Revenue (TTM)
Upcoming Events
JAN
01
January 1, 2026 - April 30, 2026
Clinical
Phase 3 acute schizophrenia trial
Initiation of Phase 3 trial for acute schizophrenia in early 2026
JAN
01
January 1, 2026 - April 30, 2026
Clinical
Phase 2 bipolar depression trial
Initiation of Phase 2 trial for bipolar depression in early 2026
JAN
01
January 1, 2026 - March 31, 2026
Clinical
Phase 3 schizophrenia trial start
Acute schizophrenia Phase 3 trial begins
JAN
01
January 1, 2026 - March 31, 2026
Clinical
Phase 2 bipolar trial start
Potentially registrational bipolar depression trial begins
JAN
01
January 1, 2026 - December 31, 2026
Clinical
Phase 3 trial start
Planned Phase 3 schizophrenia trial initiation
JAN
01
January 1, 2026 - December 31, 2026
Clinical
Phase 2 trial start
Planned Phase 2 bipolar depression trial initiation
DEC
10
December 10, 2026 - December 10, 2029
Corporate
Option vesting schedule
25% vests on Dec 10, 2026; remaining monthly installments through Dec 10, 2029.
JUL
01
July 1, 2027 - December 31, 2027
Clinical
Phase 3 schizophrenia topline
Topline results for acute schizophrenia trial
JAN
01
January 1, 2028 - March 31, 2028
Clinical
Phase 2 bipolar topline
Topline results for bipolar depression trial
DEC
10
December 10, 2035
Corporate
Option expiration
10-year option term ends; option expires if unexercised.
Short Interest History
Last 12 Months
Loading short interest data...
Days to Cover History
Last 12 Months
Loading days to cover data...
Frequently Asked Questions
What is the current stock price of LB Pharmaceuticals (LBRX)?
The current stock price of LB Pharmaceuticals (LBRX) is $21.53 as of December 26, 2025.
What is the market cap of LB Pharmaceuticals (LBRX)?
The market cap of LB Pharmaceuticals (LBRX) is approximately 556.6M. Learn more about what market capitalization means .
What is the net income of LB Pharmaceuticals (LBRX)?
The trailing twelve months (TTM) net income of LB Pharmaceuticals (LBRX) is $3,556.
What is the earnings per share (EPS) of LB Pharmaceuticals (LBRX)?
The diluted earnings per share (EPS) of LB Pharmaceuticals (LBRX) is $0.61 on a trailing twelve months (TTM) basis. Learn more about EPS .
What is the operating cash flow of LB Pharmaceuticals (LBRX)?
The operating cash flow of LB Pharmaceuticals (LBRX) is $17,105. Learn about cash flow.
What is the current ratio of LB Pharmaceuticals (LBRX)?
The current ratio of LB Pharmaceuticals (LBRX) is 47.60, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.